%PDF-1.3
%
33 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
26 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
8 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
14 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
24 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
34 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
9 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
13 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
20 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
25 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
28 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
4 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
19 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
1 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
23 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
32 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
22 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
3 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
15 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
18 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
30 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
6 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
21 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
12 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
7 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
11 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
16 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
17 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
31 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
29 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
10 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
5 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
27 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
36 0 obj
<>stream
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
Arbortext Advanced Print Publisher 9.0.114/W
2015-02-05T05:17:40-08:00
2015-01-19T19:17:42+05:30
application/pdf
untitled
uuid:9fd59a38-0b2d-43de-ad0a-f837f55d7bec
uuid:f956483a-31dc-4800-9ed0-f222d5f21d12
endstream
endobj
37 0 obj
<>stream
x+ |
endstream
endobj
38 0 obj
<>stream
xS**T0T0 Bid]D. qdj
endstream
endobj
39 0 obj
<>stream
x+ |
endstream
endobj
40 0 obj
<>stream
xS**T0T0 Bih]D. r^j
endstream
endobj
41 0 obj
<>stream
x+ |
endstream
endobj
42 0 obj
<>stream
xS**T0T0 Bid]%D. rs
endstream
endobj
43 0 obj
<>stream
x+ |
endstream
endobj
44 0 obj
<>stream
xS**T0T0 Bil]D. pa
endstream
endobj
45 0 obj
<>stream
x+ |
endstream
endobj
46 0 obj
<>stream
xS**T0T0 Bid]1D. pa
endstream
endobj
47 0 obj
<>stream
x+ |
endstream
endobj
48 0 obj
<>stream
xS**T0T0 BiU !D. _e1
endstream
endobj
49 0 obj
<>stream
x+ |
endstream
endobj
50 0 obj
<>stream
xS**T0T0 BiU)D* 9V
endstream
endobj
51 0 obj
<>stream
x+ |
endstream
endobj
52 0 obj
<>stream
xS**T0T0 Bih] D. pa
endstream
endobj
53 0 obj
<>stream
x+ |
endstream
endobj
54 0 obj
<>stream
xS**T0T0 BiUD* 8
endstream
endobj
55 0 obj
<>stream
x+ |
endstream
endobj
56 0 obj
<>stream
xS**T0T0 Bih]9D. qaj
endstream
endobj
57 0 obj
<>stream
x+ |
endstream
endobj
58 0 obj
<>stream
xS**T0T0 BiUD* :
endstream
endobj
61 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
10.4607 0 0 10.4607 62.022 712.3463 Tm
0 0 0 rg
0 Tc
0 Tw
[(dollars)-646.1(by)-641.3(2020.)-643.5(During)-647.3(the)-641.7(last)-645.1(decades,)-643.3(the)]TJ
0 -1.1923 TD
[(number)-604.4(of)-597.8(wound)-598.9(dressings,)-605.1(biopharm)-10(aceutical)]TJ
0 -1.1869 TD
[(formulat)-9.6(ions,)-246.7(and)-245.6(skin)-250.4(substitutes)-255.2(available)-248.2(in)-250.1(the)]TJ
0 -1.1923 TD
[(market)-355.8(exploded.)-359.6(However,)-353.7(no)-349.3(generall)-10.3(y)-347.8(satis)-8.2(fac-)]TJ
T*
[(tory)-381.5(cli)-7.5(nical)-380.6(solu)-7.4(tion)-378.5(for)-383.8(chronic)-385.6(wounds)-384.8(is)-379(avail-)]TJ
0 -1.1869 TD
[(able)-295.2(toda)-7.1(y.)]TJ
7.8454 0 0 6.9729 114.8598 654.7463 Tm
(4,5)Tj
10.4607 0 0 10.4607 128.8063 650.0975 Tm
[(A)-295.5(partic)-11(ular)-297(interest)-301.1(has)-294.5(been)-299.9(given)]TJ
-6.3843 -1.1923 TD
[(to)-410.3(growth)-417.3(factors,)-412.4(whic)-8.4(h)-410.3(are)-408.7(key)-414.6(signaling)-415.7(mole-)]TJ
T*
[(cules)-292.1(regulating)-292.6(tissue)-291.7(repair)-291.7(and)-288.9(regeneration.)]TJ
7.8454 0 0 6.9729 293.2157 629.8014 Tm
(6,7)Tj
10.4607 0 0 10.4607 62.022 612.7368 Tm
[(However,)-543.4(although)-539.7(a)-537.3(number)-539.4(of)-538.2(growth)-536.5(factors)]TJ
T*
[(involved)-319(in)-315.1(skin)-315.5(repair)-318.8(have)-318.5(been)-310.7(identi)-9.4(ed,)-314.6(their)]TJ
T*
[(translati)-9.7(on)-392.6(to)-388.6(the)-392.4(clinic)-395.9(has)-392.1(been)-392(very)-393.6(limite)-9.2(d,)]TJ
7.8454 0 0 6.9729 293.2157 592.4408 Tm
(8,9)Tj
10.4607 0 0 10.4607 62.022 575.3762 Tm
[(additio)-8.8(nally)-557.6(facing)-555.7(issues)-554.7(relate)-8.4(d)-549.9(t)0(o)-556.6(safety)-553.2(and)]TJ
T*
[(cost-ef)-8.5(fectiveness.)]TJ
7.8454 0 0 6.9729 148.8755 567.5526 Tm
(10)Tj
10.4607 0 0 10.4607 162.5952 562.9038 Tm
[(These)-486.6(problems)-489(derive)-488.1(most)]TJ
-9.6144 -1.1923 TD
[(likely)-194(from)-192.5(the)-186.5(fact)-190.7(that)-193.9(the)-186.5(growth)-195.1(factors)-194.8(are)-186.5(used)]TJ
0 -1.1869 TD
[(at)-553.4(vastly)-560.3(supra-physiol)-12.5(ogical)-555.2(levels)-558.3(without)-555(ap-)]TJ
0 -1.1923 TD
[(propriate)-222.1(delivery)-215(system)-8.5(s.)]TJ
7.8454 0 0 6.9729 191.9621 530.192 Tm
(8,11)Tj
10.4607 0 0 10.4607 209.4236 525.5432 Tm
[(Therefore,)-219.7(design)-216.8(of)]TJ
-14.091 -1.1923 TD
[(control)-8.8(led)-350.3(release)-351.3(strategies)-355.9(for)-345.9(dose)-349.2(reduct)-10.3(ion)-346.2(in)]TJ
0 -1.1869 TD
[(additio)-8.8(n)-182.7(t)0(o)-188.1(temporal)-188.1(and)-185.9(spati)-8.1(al)-182(do)-6.5(se)-185.5(localization)-191.3(is)]TJ
0 -1.1923 TD
[(an)-600.8(ongoing)-605.3(challenge.)-605.6(Lately,)-600.1(the)-603.8(extracellula)-10.6(r)]TJ
T*
[(matrix)-205.6(\(ECM\))-208.2(has)-202.4(become)-209.2(a)-201.3(source)-209.9(of)-202.1(inspiration)-211.5(to)]TJ
0 -1.1869 TD
[(scientis)-9.6(ts)-571.5(designin)-11.6(g)-570(growth)-579.9(factor)-576.9(delivery)-583.6(sys-)]TJ
0 -1.1923 TD
[(tems.)-379.6(In)-383.7(fact,)-381.2(the)-381.6(ECM)-381(plays)-383.2(a)-374.8(fundamen)-9.3(tal)-376.9(role)]TJ
T*
[(in)-515.6(co)-6.8(ordinating)-521.8(growth)-520.3(factor)-522.7(signaling)]TJ
/F11 1 Tf
19.5215 0 TD
[(in)-516.3(vivo,)]TJ
/F5 1 Tf
-19.5215 -1.1869 TD
[(by)-641.3(displaying)-644.4(and)-641.2(releasi)-8.1(ng)-638.9(them)-640.1(in)-634.8(a)-640.3(highly)]TJ
0 -1.1923 TD
[(spatio-t)-9.5(emporal)-600.2(control)-8.8(led)-599.6(manner)-604.4(and)-597.8(also)-606(by)]TJ
T*
[(modulating)-652.8(their)-652.3(intracell)-10.2(ular)-649.3(signaling.)-654.9(Thus,)]TJ
0 -1.1869 TD
[(unders)-8.8(tanding)-599.3(how)-592.6(the)-593(ECM)-597.8(regulates)-601.1(growth)]TJ
0 -1.1923 TD
[(factors)-644.6(and)-646.6(engineering)-645.4(delivery)-648.6(systems)-645.2(inte-)]TJ
T*
[(grating)-380(these)-377.4(regulat)-9.1(ory)-376.3(features)-378.6(could)-378.6(be)-373.4(key)-376.7(to)]TJ
0 -1.1869 TD
[(making)-502.6(growth)-504(factor-bas)-9.7(ed)-499.7(therapies)-505.1(a)-499.4(reality.)]TJ
0 -1.1923 TD
[(In)-253.6(this)-252.5(review,)-258.3(we)-247.3(highlight)-258.7(variou)-9.3(s)-246.5(ECM-insp)-10.5(ired)]TJ
T*
[(technolo)-8.4(gies)-416.4(that)-416.1(have)-416.1(been)-413.7(develop)-9.5(ed)-413(to)-415.7(deliver)]TJ
0 -1.1869 TD
[(growth)-287.2(factors)-286.9(for)-280.8(skin)-283(wound)-284.6(healing.)]TJ
/F2 1 Tf
10.959 0 0 10.959 62.022 283.9747 Tm
[(TRANSLATIONA)6(L)-332.6(RELEVANCE)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 73.9842 270.0283 Tm
[(Chronic)-607.8(wounds)-607(are)-609.2(stubborn)-609.3(to)-610.8(close,)-607.4(even)]TJ
-1.1435 -1.1923 TD
[(with)-200.5(extensive)-196(medical)-197.4(care.)-195.5(Therefore,)-198(since)-194.5(many)]TJ
T*
[(growth)-455.2(factors)-454.9(have)-454(been)-451.7(recognized)-453.4(as)-458.7(key)-452.5(sig-)]TJ
0 -1.1869 TD
[(naling)-393.5(molecules)-393(inducing)-396.4(wound)-392.9(healing,)]TJ
7.8454 0 0 6.9729 270.0283 237.3165 Tm
(12)Tj
10.4607 0 0 10.4607 282.7841 232.6676 Tm
(they)Tj
-21.104 -1.1923 TD
[(have)-426.9(been)-424.6(explored)-429.6(in)-428.9(the)-425(clinic)-433.8(to)-426.5(treat)-424.5(chronic)]TJ
T*
(wounds.)Tj
7.8454 0 0 6.9729 101.9905 212.3716 Tm
(13,14)Tj
10.4607 0 0 10.4607 124.4976 207.7228 Tm
[(For)-283.9(example,)-284.8(platelet-derived)-281.5(growth)]TJ
-5.9724 -1.1869 TD
[(factor-BB)-189.9(\(PDGF-BB\))-193.5(is)-189.3(crucial)-196.6(for)-188.7(the)-191.9(formation)-192.4(of)]TJ
0 -1.1923 TD
[(granulation)-388.4(tissue)-389.3(and)-391.9(for)-389.2(stem)-389.7(cell)-390.9(recruitment,)]TJ
T*
[(vascular)-342.2(endothelial)-333.3(growth)-341.4(factor-A)-338.8(\(VEGF-A\))-337.2(is)]TJ
0 -1.1869 TD
[(necessary)-490.7(to)-486.2(induce)-490.8(the)-490(growth)-487.8(of)-489.4(blood)-485.1(vessels)]TJ
0 -1.1923 TD
[(that)-291.4(sustain)-292.3(the)-294.9(granulation)-290.9(tissue,)-292.5(and)-294.3(broblast)]TJ
T*
[(growth)-406.5(factors)-400.7(\(FGFs\),)-405.8(especially)-404.1(FGF-2,)-400.9(are)-403.3(im-)]TJ
0 -1.1869 TD
[(portant)-457.9(for)-459.7(both)-452.8(wound)-458(reepithelization)-459.4(and)-456.9(an-)]TJ
0 -1.1923 TD
(giogenesis.)Tj
7.8454 0 0 6.9729 114.5197 112.7621 Tm
(15,16)Tj
/F2 1 Tf
10.959 0 0 10.959 62.022 78.7464 Tm
[(CLINICAL)-329.6(RELEVANCE)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 73.9842 64.8 Tm
[(Even)-450.6(if)-449.8(growth)-444.4(factors)-449.5(are)-452(very)-447.7(promising)-448(for)]TJ
-1.1435 -1.1923 TD
[(wound)-224.9(healing,)-224.9(their)-224.2(translation)-223.5(into)-221.3(the)-224.4(clinic)-227.8(has)]TJ
T*
[(been)-402.9(seriously)-399.6(limited.)]TJ
7.8454 0 0 6.9729 173.6503 44.5039 Tm
(17)Tj
10.4607 0 0 10.4607 186.5196 39.8551 Tm
[(For)-403.1(instance,)-400.3(PDGF-BB)]TJ
13.5274 64.2875 TD
[(\(B)21.3(ec)20.2(ap)18.4(le)20.7(rm)20.5(in)-304.3(i)13.9(n)-312.8(Re)20.3(gr)17.9(an)22.5(e)12.2(x)]TJ
/F10 1 Tf
7.8454 0 0 6.9729 453.0329 716.9951 Tm
()Tj
/F5 1 Tf
10.4607 0 0 10.4607 459.1558 712.3463 Tm
[(\))-311.9(i)0(s)-303.1(c)13.4(om)19.3(m)12.4(e)0(r)20.2(c)0(i)16.5(a)0(l)24(l)0(y)-306.8(a)15.5(va)19.9(il)17(-)]TJ
-12.5356 -1.1923 TD
[(ab)20.1(le)-320.7(f)13.2(o)0(r)-321.2(c)0(h)20.4(r)0(o)20.3(n)0(i)20.9(c)-333.4(w)11.4(o)12.2(un)19.4(d)-327.7(t)0(r)19.1(e)0(a)16.9(t)11(m)12.4(e)12.2(nt)18.1(,)-331.4(b)0(u)22.5(t)-330.4(t)11(h)0(e)-322.2(p)13.8(ro)20.2(du)15.4(c)13.4(t)]TJ
0 -1.1869 TD
[(received)-332.4(a)-320.6(boxed)-326.6(warning)-328.3(from)-322.6(the)-327.4(U.S.)-320.6(Food)-325.5(and)]TJ
0 -1.1923 TD
[(Drug)-364.7(Administration)-369.6(and)-359.4(has)-359.6(been)-359.5(wit)-7(hdrawn)-360(in)]TJ
T*
[(Europe)-209.7(due)-210.9(to)-204.3(saf)-6.5(ety)-205.3(issues.)-214.1(Indeed,)-207.8(PDGF-BB)-214.6(was)]TJ
0 -1.1869 TD
[(used)-430.3(as)-426.2(supra-physi)-11.6(ological)-431.5(doses)-427.7(and)-429.8(treatment)]TJ
0 -1.1923 TD
[(with)-254.7(the)-251.5(growth)-254.7(factor)-257.1(correlated)-259(with)-254.7(a)-250.1(ve-times)]TJ
T*
[(increased)-394.3(risk)-390.3(of)-386.4(can)-7.5(cer.)]TJ
7.8454 0 0 6.9729 448.4408 629.8014 Tm
(17)Tj
10.4607 0 0 10.4607 461.1967 625.1526 Tm
[(The)-387.8(problems)-391.5(encoun-)]TJ
-12.7307 -1.1869 TD
[(tered)-544.3(with)-536.5(PDGF-BB)-545.2(illustrate)-546.4(well)-539.2(the)-538.8(impor-)]TJ
0 -1.1923 TD
[(tance)-325.6(of)-321.4(control)-8.8(ling)-323.8(the)-322(spati)-8.1(o-temporal)-325.2(release)-329.6(of)]TJ
T*
[(growth)-368.5(factors)-362.8(at)-363.7(the)-359.9(wound)-365.8(site)-366.5(and)-359.4(overcoming)]TJ
0 -1.1869 TD
[(this)-447.6(challenge)-447.7(is)-444(probabl)-8.6(y)-440(the)-446.6(key)-441.7(for)-443.4(success)-10.6(ful)]TJ
0 -1.1923 TD
[(growth)-287.2(factor-based)-287.2(therap)-8.3(ies.)]TJ
/F2 1 Tf
10.959 0 0 10.959 328.0251 526.8471 Tm
[(BACKGROUND:)-327.3(THE)-335.4(ECM)-333.7(AS)-333.5(A)-332.2(REGULATO)7.8(R)]TJ
0 -1.1381 TD
[(OF)-332.8(GROWTH)-328.7(FACTOR)-333(SIGNALING)]TJ
9.9626 0 0 9.9626 328.0251 500.7117 Tm
[(Key)-335.5(ECM)-339.4(mo)-9.6(lecules)-339.2(invol)-8.2(ved)]TJ
0 -1.2519 TD
[(in)-334.2(wou)-9.6(nd)-336.9(healin)-8.2(g)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 339.9873 475.7668 Tm
[(Although)-590.4(skin)-591.9(matrix)-590.4(composition)-590.3(and)-592.4(prop-)]TJ
-1.1435 -1.1869 TD
[(erties)-546.8(evolve)-547.4(with)-547.3(aging,)-546.2(the)-549.6(environment,)-548.9(and)]TJ
0 -1.1923 TD
[(disease,)-729.8(the)-728.5(principal)-732.2(ECM)-733.3(molecules)-729(remain)]TJ
T*
[(qualitatively)-443.8(the)-441.2(same)-444.9(and)-440.7(can)-446.4(be)-443.8(schematically)]TJ
0 -1.1869 TD
[(divided)-445.2(in)-450.6(two)-442.2(categories.)-447.8(The)-442(rst)-448.1(one)-445.4(includes)]TJ
0 -1.1923 TD
[(brous)-305.2(structural)-308.7(proteins)-303.8(and)-305.2(adhesive)-308.3(glycopro-)]TJ
T*
[(teins,)-268.2(which)-267(provide)-268.4(the)-267.8(core)-268.4(structure)-266.3(and)-267.2(tensile)]TJ
0 -1.1869 TD
[(strength)-359.1(of)-353.9(the)-354.5(tissue,)-357.6(connect)-357.1(the)-354.5(matrix)-357.4(compo-)]TJ
0 -1.1923 TD
[(nents,)-519(and)-516.5(display)-523.5(adhesion)-517.1(sites)-515.5(for)-519.3(cells.)-519(The)]TJ
T*
[(second)-307.1(category)-308.8(consists)-302.6(of)-310.5(proteoglycans)-302.5(and)-310.6(gly-)]TJ
0 -1.1869 TD
[(cosaminoglycans)-195.8(\(GAGs\),)-195.4(which)-201.9(are)-197.3(made)-195.4(of)-196.7(highly)]TJ
0 -1.1923 TD
[(hydrophilic)-187.4(polysaccharides)-189.6(chains)-189.7(and)-185.9(provide)-187.1(the)]TJ
T*
[(gel-like)-369(compressive)-374(properties)-368.9(of)-370.2(the)-370.8(tissue.)-373.8(Col-)]TJ
0 -1.1869 TD
[(lagens)-323.5(are)-327.4(the)-327.4(main)-325.1(class)-325.6(of)-326.8(brous)-326.9(proteins)-325.4(com-)]TJ
0 -1.1923 TD
[(posing)-227.6(the)-229.8(healthy)-226.9(dermal)-227.6(ECM,)-230(more)-231.5(particularly)]TJ
T*
[(type)-381.2(I)-374.4(collagen)-378.8(\(about)-375.4(80%\))-380.2(and)-375.6(type)-381.2(III)-375.4(collagen)]TJ
0 -1.1869 TD
[(\(about)-521.7(10%\))-515.7(that)-519.1(are)-522.5(organized)-517.8(into)-519.4(a)-521.1(partially)]TJ
0 -1.1923 TD
[(cr)16(o)12.2(s)13.6(s-)16(l)13.9(i)0(n)15.5(k)13.1(ed)-239.5(ne)19.2(t)11(w)0(o)18.2(r)0(k)21.1(.)-250.1(T)10.2(h)0(i)15.5(s)-246.5(ne)19.2(t)11(w)11.4(or)20.3(k)-252.5(i)0(s)-243.5(i)13.9(nt)18.1(e)12.2(r)0(m)20.5(i)0(n)15.5(g)0(l)23.8(e)0(d)]TJ
T*
[(w)11.4(i)0(t)19.6(h)-215.2(bu)22.5(nd)15.4(l)13.9(e)0(s)-207.2(o)12.2(f)-214.4(e)0(l)20.7(a)0(s)18.2(t)11(ic)-205.7()12.4(b)0(e)16.9(r)13.4(s)-214(m)0(a)17.1(d)13.8(e)-215.4(o)0(f)-207.6(a)-212.2(h)12.4(i)0(g)18.4(h)0(l)20.9(y)-217.7(cr)21.4(os)20.4(s-)]TJ
0 -1.1869 TD
[(linked)-462.6(elastin)-460.2(co)-6.8(re)-456.7(surrounded)-466.4(by)-457(brill)-9(in)-456(mole-)]TJ
0 -1.1923 TD
[(cules)-227(at)-222.8(the)-224.4(periphery.)-227.1(These)-226.5(bers)-225.5(are)-224.4(essential)-228.4(to)]TJ
T*
[(provid)-9.7(e)-573.1(the)-576.7(skin)-581(its)-573.8(stretch)-10.3(ing)-576.2(and)-576.2(compliance)]TJ
0 -1.1869 TD
[(properties)-11.2(.)-326(I)0(n)-329.5(this)-328.4(collagen-ela)-9.6(stin)-328.4(scaffold)-10.3(,)-326(glyco-)]TJ
0 -1.1923 TD
[(proteins)-688.6(such)-690.6(as)-680.9(bronectin)-694.7(and)-684.6(other)-686.5(matri-)]TJ
T*
[(cellular)-200.1(proteins)-195.4(\()]TJ
/F11 1 Tf
8.0156 0 TD
(e.g.,)Tj
/F5 1 Tf
2.0269 0 TD
[(osteopont)-8.4(in,)-191.2(vitronec)-9.8(tin,)-191(and)]TJ
-10.0425 -1.1869 TD
[(tenascin)-9.2(\))-393.2(are)-392.4(bound.)-395.1(Importa)-8.7(ntly,)-392.5(most)-395.1(glycopr)-11(o-)]TJ
0 -1.1923 TD
[(teins)-337.8(have)-334.8(the)-332.8(ability)-339.9(to)-329(intera)-8.2(ct)-333.2(with)-336(soluble)-334.3(sig-)]TJ
T*
[(naling)-501.8(molecules)-506.8(such)-500.9(as)-496.6(growth)-504(factors)-503.7(and)-500.3(to)]TJ
0 -1.1869 TD
[(present)-236.4(cell)-233.7(adhesion)-235.3(sites.)]TJ
7.8454 0 0 6.9729 456.4345 131.7543 Tm
(1820)Tj
10.4607 0 0 10.4607 480.4723 127.1055 Tm
[(Conc)-8(erning)-234.6(GAGs,)]TJ
-14.5733 -1.1923 TD
[(hyaluronan)-325.1(is)-319.3(the)-322(predominant)-322.8(one)-320.8(in)-320.5(the)-322(dermal)]TJ
T*
[(interstitial)-548.5(matrix,)-542.4(the)-538.8(oth)-7.6(ers)-535.2(being)-543.1(dermatan-,)]TJ
0 -1.1869 TD
[(chondroi)-9.9(tin-,)-335(heparan-,)-336.7(and)-332.3(keratan-s)-10(ulfates.)-337(The)]TJ
0 -1.1923 TD
[(ECM)-543.6(compositions)-544.2(of)-543.6(basement)-540(membranes,)-547.7(lo-)]TJ
T*
[(cated)-687.4(beneath)-683.7(the)-685.1(epidermis)-693.6(and)-684.6(surrounding)]TJ
0 -1.1869 TD
[(blood)-436.4(and)-435.3(lympha)-8.8(tic)-433.1(vessels)-8.5(,)-434.4(differ)-435(from)-436.4(the)-435.8(one)]TJ
0 -1.1923 TD
[(described)-615.2(abo)-5.6(ve)-606.6(and)-608.7(are)-614.6(mainly)-610.2(const)-7.7(ituted)-613.8(of)]TJ
ET
1 i
q 1 0 0 1 62.022 754.412 cm 0 0 m
508.082 0 l
508.082 -.51 l
0 -.51 l
f*
Q
BT
/F12 1 Tf
8.9663 0 0 8.9663 62.022 758.6644 Tm
(2)Tj
/F13 1 Tf
9.9626 0 0 9.9626 230.9669 758.6644 Tm
[(BRIQUE)-12.6(Z,)-333.6(HUBB)-9(ELL,)-334.1(AND)-344.9(MARTINO)]TJ
ET
endstream
endobj
72 0 obj
<>stream
/GS1 gs
BT
/F5 1 Tf
10.4607 0 0 10.4607 41.8394 388.6865 Tm
0 0 0 rg
0 Tc
0 Tw
[(non-bril)-10.5(lar)-520.8(collagen)-530.6(IV,)-518.9(lam)-6.9(inin,)-522.6(and)-522(entactin,)]TJ
0 -1.1923 TD
[(and)-207.6(enriched)-210.4(in)-206.7(perlecan)-207.4(and)-207.6(heparan)-208.3(sulfates)]TJ
7.8454 0 0 6.9729 262.2614 380.8629 Tm
(2123)Tj
10.4607 0 0 10.4607 41.8394 363.7416 Tm
[(\(Fig.)-284.1(1\).)]TJ
1.1435 -1.1869 TD
[(Following)-691.9(skin)-689.4(injury,)-688.3(the)-690.5(original)-691.5(ECM)-689.9(is)]TJ
-1.1435 -1.1923 TD
[(damaged)-270(and)-272.7(a)-266.4(provisional)-272.5(brin)-268.3(matrix)-270.6(is)-270.6(formed)]TJ
T*
[(within)-255.4(the)-251.5(wound)-252(by)-251.1(the)-251.5(coagulation)-253.1(cascade.)-250.2(This)]TJ
0 -1.1869 TD
[(matrix)-601.2(is)-601.2(mainly)-599.4(constituted)-599.8(of)-597.8(brinogen)-600.9(and)]TJ
0 -1.1923 TD
[(contains)-198.9(plasma)-202.6(bronectin)-201.5(to)-198.9(some)-198.8(extent.)-202.9(During)]TJ
T*
[(the)-240.7(process)-243.7(of)-245.5(repair,)-243.7(the)-240.7(brin)-246.7(matrix)-238.1(is)-243.5(gradually)]TJ
0 -1.1869 TD
[(degraded)-345.2(by)-343.2(immune)-346.8(cells)-344.8(migrating)-342.8(into)-346(the)-343.7(clot)]TJ
0 -1.1923 TD
[(and)-559.9(replaced)-563.7(by)-560(a)-564.4(characteristic)-561.6(collagen-based)]TJ
T*
[(matrix)-362.8(having)-359.6(an)-362.3(excessive)-360.5(proportion)-359.2(of)-359.3(type)-364.9(III)]TJ
0 -1.1869 TD
[(collagen)-227.1(\(about)-229(2025%\))-225.4(compared)-229.2(to)-226(healthy)-232.3(skin,)]TJ
0 -1.1923 TD
[(and)-413.6(the)-414.1(levels)-417.4(of)-413.5(other)-415.5(important)-409.9(ECM)-418.9(proteins,)]TJ
T*
[(notably)-429.8(bronectin,)-435.4(tenascin)-432(C,)-431.8(and)-435.2(hyaluronan,)]TJ
0 -1.1869 TD
[(are)-462.9(also)-465.1(increased.)-465.6(During)-463(the)-468.3(subsequent)-459.8(long-)]TJ
0 -1.1923 TD
[(term)-384.4(remodeling)-388.3(phase,)-383.1(the)-387(network)-385.6(of)-386.4(elastic)-388.7(-)]TJ
T*
[(bers)-243.3(reestablishes)]TJ
7.8454 0 0 6.9729 130.6771 181.5874 Tm
(24)Tj
10.4607 0 0 10.4607 141.9023 176.9385 Tm
[(and)-251(the)-240.7(matrix)-249(reorganizes)-243(to)]TJ
-9.5656 -1.1869 TD
[(reach)-290.7(a)-293.5(composition)-292.2(closer)-295.1(to)-291.1(the)-289.5(initial)-295.6(skin)-293.8(ECM)]TJ
0 -1.1923 TD
[(\(Fig.)-278.7(1\).)]TJ
/F2 1 Tf
9.9626 0 0 9.9626 41.8394 127.2189 Tm
[(Grow)-9.5(th)-332.6(factor)-343.7(regulat)-8.5(ory)-338.2(function)-11.3(s)]TJ
0 -1.2519 TD
[(of)-339.1(the)-332.6(ECM)-339.4(dur)-8.8(ing)-334.7(wou)-9.6(nd)-336.9(healing)]TJ
/F5 1 Tf
10.4607 0 0 10.4607 53.8015 102.274 Tm
[(More)-218.2(than)-219.6(a)-217.6(ber)-217.4(network)-217.6(providing)-222.7(mechanical)]TJ
-1.1435 -1.1869 TD
[(cues,)-333.9(the)-332.8(ECM)-332.2(is)-330.2(a)-336.8(highly)-334(dynamic)-331.4(microenviron-)]TJ
0 -1.1923 TD
[(ment,)-391.6(which)-391.6(controls)-390.8(a)-391(multitude)-385.3(of)-391.8(cellular)-395.2(pro-)]TJ
T*
[(cesses)-349.4(during)-346.8(wound)-344.2(healing.)-349.5(One)-348.7(of)-343.1(the)-349.1(primary)]TJ
0 -1.1869 TD
[(functions)-410.9(of)-413.5(the)-414.1(ECM)-413.5(is)-411.5(to)-410.3(provide)-414.7(a)-412.7(scaffold)-411.3(for)]TJ
0 -1.1923 TD
[(migrating)-304.9(cells,)-302.2(since)-302.9(collagen)-302.9(and)-305.2(ECM)-305.1(glycopro-)]TJ
25.4288 33.3306 TD
[(teins)-234.8(display)-236.2(a)-233.8(number)-235.9(of)-234.7(cell-binding)-237(sites)-233.7(such)-235.4(as)]TJ
0 -1.1923 TD
[(for)-389.2(integrin)-383(receptors.)-389.4(Integrins,)-384.6(which)-391.6(recognize)]TJ
T*
[(short)-441.3(sequences)-440.5(present)-442.3(in)-445.2(many)-437.5(ECM)-446(proteins,)]TJ
0 -1.1869 TD
[(such)-213.7(as)-209.4(collagen,)-211.6(bronectin,)-213.2(and)-213(vitronectin,)]TJ
7.8454 0 0 6.9729 523.3889 355.9747 Tm
(25)Tj
10.4607 0 0 10.4607 534.2739 351.3259 Tm
(are)Tj
-21.6459 -1.1923 TD
[(one)-505.1(of)-505.6(the)-506.2(major)-506.3(classes)-505.7(of)-511.1(transmembrane)-499.9(cell)]TJ
T*
[(surface)-610.7(receptors)-610.8(that)-605.8(allow)-610.5(cellECM)-610.1(interac-)]TJ
0 -1.1869 TD
[(tions.)-251.9(Importantly,)-254.9(integrins)-250.2(not)-251.5(only)-255(serve)-252.9(for)-248.3(cell)]TJ
0 -1.1923 TD
[(adhesion)-322(and)-321.4(migration,)-319.6(but)-318.8(they)-322.9(also)-318.7(regulate)-322.1(or)]TJ
T*
[(induce)-485.4(a)-488.6(number)-479.8(of)-489.4(cellular)-482(processes)-488.8(including)]TJ
0 -1.1869 TD
-.0002 Tc
[(proliferation)-278.7(and)-283.7(differentiation.)]TJ
1.1435 -1.1923 TD
0 Tc
[(Besides)-281.1(providing)-287.8(cell-adhesion)-282.4(sites,)-283.3(one)-288.3(of)-283.4(the)]TJ
-1.1435 -1.1923 TD
[(most)-265(important)-269(functions)-264.6(of)-267.2(the)-267.8(ECM)-267.2(is)-270.6(to)-264(act)-269(as)-269(a)]TJ
0 -1.1869 TD
[(reservoir)-416.7(for)-416.3(growth)-417.3(factors.)-412.4(Throughout)-417.7(the)-414.1(dif-)]TJ
0 -1.1923 TD
[(ferent)-315.6(phases)-319.9(of)-316(the)-316.6(healing)-321.6(process,)-315(immune)-319.7(and)]TJ
T*
[(tissue-resident)-473.8(cells)-480.3(secrete)-475.4(a)-477.7(multitude)-477.4(of)-473.1(cyto-)]TJ
0 -1.1869 TD
[(kines)-227.4(and)-229.3(growth)-227.6(factors,)-228.1(which)-229(strongly)-234.1(modulate)]TJ
0 -1.1923 TD
[(cell)-222.9(behavior.)-220.9(Many)-223.8(growth)-222.2(factors)-221.9(have)-221(the)-224.4(ability)]TJ
T*
[(to)-318.1(bind)-312.9(specic)-319(sites)-315(within)-315(the)-311.1(ECM)]TJ
7.8454 0 0 6.9729 487.6723 181.5874 Tm
(26,27)Tj
10.4607 0 0 10.4607 510.5196 176.9385 Tm
[(and)-310.6(will)]TJ
-19.3751 -1.1869 TD
[(thus)-492.5(rst)-496.9(interact)-493.1(with)-493.1(the)-490(ECM)-494.8(before)-490.2(nding)]TJ
0 -1.1923 TD
[(their)-381.3(cognate)-379.3(cell-surface)-375.9(receptor)-380.5(\(Fig.)-381.7(2A\).)-381.4(Sev-)]TJ
T*
[(eral)-530.3(growth)-536.5(factors)-530.8(possess)-530.6(specic)-535.8(interactions)]TJ
0 -1.1869 TD
[(with)-493.1(heparan)-495.5(sulfate)-493.4(proteoglycans)-492.2(of)-494.8(the)-495.4(ECM)]TJ
0 -1.1923 TD
-.0001 Tc
[(and)-451.6(they)-447.7(are)-452.2(often)-448.3(described)-452.7(as)-453.4(heparin-binding)]TJ
T*
0 Tc
[(growth)-552.8(factors.)]TJ
7.8454 0 0 6.9729 383.4141 106.8661 Tm
(28,29)Tj
10.4607 0 0 10.4607 408.7558 102.2173 Tm
[(On)-550.6(the)-555(other)-556.4(hand,)-553.7(several)]TJ
-9.6469 -1.1869 TD
[(growth)-628.7(factor-binding)-623.6(sites)-623.9(have)-627.4(been)-625.1(recently)]TJ
0 -1.1923 TD
[(discovered)-326.7(within)-325.9(ECM)-326.8(proteins)-325.4(such)-327.5(as)-323.2(bronec-)]TJ
0 -1.1869 TD
(tin,)Tj
7.8454 0 0 6.9729 324.5101 69.5622 Tm
(18)Tj
10.4607 0 0 10.4607 335.9054 64.9134 Tm
(brinogen,)Tj
7.8454 0 0 6.9729 387.9495 69.5622 Tm
(30)Tj
10.4607 0 0 10.4607 399.3448 64.9134 Tm
[(tenascin)-258.5(C,)]TJ
7.8454 0 0 6.9729 453.1464 69.5622 Tm
(19)Tj
10.4607 0 0 10.4607 464.5416 64.9134 Tm
[(and)-261.8(vitronectin,)]TJ
7.8454 0 0 6.9729 541.3038 69.5622 Tm
(20)Tj
10.4607 0 0 10.4607 307.8424 52.4409 Tm
[(which)-429.6(are)-424.9(present)-431.5(in)-423.5(the)-430.4(provisional)-429.6(matrix)-427.8(and)]TJ
0 -1.1923 TD
[(under)-195.8(the)-197.3(basement)-198.6(membrane)-191.9(of)-196.7(the)-197.3(reepithelized)]TJ
ET
41.839 419.924 508.082 .51025 re
f
q
1 i
117.128 720 m
474.69 720 l
474.69 480.756 l
117.128 480.756 l
W n
q
357.566 0 0 239.244 117.128 480.756 cm
/Im4 Do
Q
Q
BT
/F1 1 Tf
7.9702 0 0 7.9702 41.8394 456.7747 Tm
[(Figure)-338.1(1.)]TJ
/F14 1 Tf
4.6662 0 TD
[(Different)-340.2(ECM)-334.3(compositions)-333.1(in)-349(healthy)-333.2(skin)-344.1(and)-342.3(during)-336.9(wound)-340.7(healing.)-338.6(\()]TJ
/F15 1 Tf
29.5906 0 TD
(Top)Tj
/F14 1 Tf
1.5009 0 TD
[(\))-337.8(Locations)-339.3(of)-342.9(the)-340.8(different)-340.4(ECM)-341.4(presen)13(t)-345(i)0(n)-349(the)-340.8(skin)-337(tissue.)-348.1(\()]TJ
/F15 1 Tf
24.8248 0 TD
(Bottom)Tj
/F14 1 Tf
2.8879 0 TD
(\))Tj
-63.4705 -1.2448 TD
[(Schematic)-233.6(representati)13.4(ons)-245.9(of)-236.2(the)-241.2(main)-240.6(ECM)-241.8(molecule)12.1(s)-243(composing)-233.4(the)-241.2(interstitial)-237.3(matrix)]TJ
/F1 1 Tf
35.3594 0 TD
(\(A\))Tj
/F14 1 Tf
1.6218 0 TD
[(and)-242.7(the)-241.2(basal)-239.3(lamina)]TJ
/F1 1 Tf
8.5571 0 TD
(\(B\))Tj
/F14 1 Tf
1.572 0 TD
[(of)-243.3(healthy)-240.7(skin,)-239.9(and)-242.7(the)-234.1(brin)-239.4(clot)]TJ
/F1 1 Tf
13.5719 0 TD
(\(C\))Tj
/F14 1 Tf
1.572 0 TD
(and)Tj
-62.2542 -1.2519 TD
[(the)-255.4(granulation)-251.4(tissue)]TJ
/F1 1 Tf
8.991 0 TD
(\(D\))Tj
/F14 1 Tf
1.6431 0 TD
[(during)-258.7(skin)-258.8(wound)-255.3(healing.)-253.2(Stars)-255.7(indicate)-254.2(ECM)-256.1(molecules)-252.3(that)-259(have)-258.1(been)-254.9(shown)-258.5(to)-257.5(have)-258.1(a)-261.1(strong)-255.8(afnity)-253.4(for)-258.8(several)-255.9(growth)-255.1(factors.)]TJ
-10.6341 -1.2519 TD
[(ECM,)-329.7(extracellul)11.1(ar)-333.6(matrix.)]TJ
ET
41.839 753.902 508.082 .51025 re
f
BT
/F13 1 Tf
9.9626 0 0 9.9626 147.2881 757.8707 Tm
[(GROWT)-10.3(H)-334.7(FACTOR)-339.3(DELI)-8.8(VERY)-337.2(SYSTEM)-11.3(S)-336.3(FOR)-339.8(WOUN)-9.5(D)-334.8(HEALI)-8.6(NG)]TJ
/F12 1 Tf
8.9663 0 0 8.9663 544.9889 757.8707 Tm
(3)Tj
ET
endstream
endobj
73 0 obj
<>stream
Adobe d
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz m !1AQa"q2#BRbr3$4CS%cs5DT
&6E'dtU7()euFVfvGWgw8HXhx9IYiy*:JZjz ? ֵ3O
>և#|"܍& ռʚ bA$mu*s%e_Vȑ3#qUBH|˽
ŗ_-Ė0=G]#'Vȁރ<ӫ7}
X 'bB&;I?r L>)_cw